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"The living being is stable" (10). This stability is dependent 
upon many regulatory mechanisms which are activated when the normal 
steady state is disturbed. The six propositions regarding factors 
maintaining the steady state in the body (Appendix A) made by Cannon 
(22) in 1925 form the assumptions upon which the work in this disserta-
tion is based. 
The earliest mechanism demonstrated for the control of parathyroid 
hormone (PTH) secretion was the blood calcium concentration (50). A 
critical experiment using bioassay was performed by Patt and Luckhardt 
(74) in 1942 which firmly established the stimulatory effect of hypo-
calcemia on PTH secretion. McLean (70) in 1957 formalized this concept 
of a parathyroid secretion regulatory mechanism. He postulated that the 
hypercalcemic hormone (PTH) secretion was controlled by a negative feed-
back of the serum calcium directly on the parathyroid. This concept was 
later verified in the cow by radioimmunoassay (RIA) in 1966 (76) (90). 
Rather than linear as the previous work implies, the PTH secretory 
response to ionized calcium was found to be inversely related in a 
sigmoid manner (18) (67) (68). This work depicts the secretory response 
of PTH as inverse and linear between 7.5 and 10.5 mg calcium/100 ml 
plasma. At concentrations greater than 10.5 mg/100 ml the PTH secretory 
rate is non-suppressible. At calcium concentrations less than 7.5 mg/ 
1 
100 ml, the rate appears to be insenitive to further stimulation by 
calcium reduction. 
A negative feedback mechanism for regulation of PTH secretion by 
magnesium was proposed by Macintyre (63) in 1963. He placed the pri-
mary site of action of PTH, as it relates to magnesium, at the kidney. 
Since the calcium/magnesium ratio in bone is about 50/1, he felt bone 
would be a primary site of action for calcium but not magnesium. PTH, 
however, is thought to equally affect calcium and magnesium retention 
by the kidney. This hypothesis implies that calcium and magnesium 
homeostasis are interdependent and that calcium homeostasis will not 
be maintained if the magnesium concentration is markedly abnormal. 
2 
Such interdependency has been recorded (45) (51). This negative feed-
back has been demonstrated "in vivo" (20) (27) and "in vitro" (88) (98) 
within the normal plasma magnesium range by RIA. There remains some 
question as to whether the inverse effect of calcium on PTH secretion 
is equipotent, on a molar basis, to magnesium (98). Extreme hypomag-
nesemia, however, appears to inhibit PTH secretion, even when accom-
panied by hypocalcemia (5) (6) (92) (96). Whether the response of the 
parathyroid gland to magnesium concentration represents a meaningful 
physiological regulatory mechanism or a pathological one is still in 
question (65) (104). 
Vitamin D has been shown to affect parathyroid gland activity. 
Capen (24) (25) (26) demonstrated that an increase in the amount of 
Vitamin D fed to cows resulted in a reduction of parathyroid prosecre-
tory granules and other structural and ultra-structural changes that 
were interpreted as indicative of a reduced secretory rate. The expo-
sure of parathyroid glands "in situ" to 24,25 dehydroxycholecalciferol 
3 
(DHCC) has been shown to reduce PTH output (15). This work indicates a 
direct inhibition of the PTH secretion. The more physiologically 
active 1,25 DHCC has also been shown to inhibit PTH secretion (30). 
This relationship may contribute to the reciprocal control of 1,25 
DHCC metabolism in the kidney. 
Epinephrine has been suggested as a secretagogue for PTH. Experi-
ments in the cow demonstrated an increase in peripheral plasma concen-
tration of immunoreactive PTH following injection of epinephrine (39). 
"In vitro" work has yielded contradictory results. Measurement of 
canine parathyroid adenyl cyclase failed to show stimulation with 
epinephrine (34). Incubation of gland slices with epinephrine, how-
ever, increased the release of hormone into the media (103). Although 
the significance of epinephrine in physiological regulation of PTH 
secretion is questionable, there does seem to be a possible correla-
tion in certain pathological conditions (1) (59) (60). 
Calcitonin has been observed to increase PTH secretion. This 
may be an indirect effect resulting from a lowered plasma calcium 
concentration or directly by promoting a transient calcium efflux 
from parathyroid cells (65). This transient efflux may be sufficient 
to lower cytosol calcium ion content and thereby activate PTH secre-
tion. The physiological significance of a direct calcitonin regula-
tion of PTH secretion is questionable. 
The anterior pituitary has been implicated by indirect evidence 
in the regulation of PTH secretion. The possibility of an anterior 
pituitary-parathyroid axis will comprise the main portion of this 
dissertation. A review of some of the more p~rtinent literature is 
made in Chapter II. 
In summary, the calcium ion concentration in plasma.is generally 
accepted as the predominate regulator of the PTH secretory rate. 
Magnesium and Vitamin D may play a lesser role in regulating para-
thyroid activity under normal, non-pathological conditions. Regula-





Indirect evidence has accumulated in the literature which suggests 
a direct functional relationship between the pituitary and the parathy-
raid glands. The evidence can be organized into three major categories: 
pituitary lesions, hypophysectomies, and anterior pituitary extract 
injections. 
Observations of pituitary lesions and concomitant abnormalities 
of bone, plasma calcium, and parathyroid tissue have been recorded. 
Several cases of pituitary adenomas involving basophilic cells have 
been reported in humans which also exhibited osteitis fibrosa cystica 
(36) (83). Marked enlargement of human pituitaries associated with 
acromegaly have also exhibited an increase in serum calcium (85). A 
case of· basophilic pituitary adenoma has been reported with adenoma-
taus hyperplasia of parathyroid glands and osteitis fibrosa (36). In 
1936, Houssay (55) reviewed 24 cases of hyperpituitarism and found 14 
instances of osteoporsis and decalcification of bone. He found these 
14 cases to have 3 parathyroid adenomas, 3 enlarged parathyroids, 1 
atrophied parathyroid, and 6 normal appearing parathyroids. 
Experimental hypophysectomy has yielded interesting and conflict-
ing results concerning serum calcium concentrations and parathyroid 
tissue responses. A number of hypophysectomy experiments on toads 
' 
resulted in a significant decrease of serum calcium concentrations 
5 
6 
(28) (53) (86) (87). Similar work on pigeons also yielded a reduction 
in serum calcium (78). Hypophysectomy in pigeons followed by injections 
of PTH were found to return the serum calcium to normal (78). A lack of 
serum calcium response to hypophysectomy was noted in dogs (42) (64) 
(69) (93) and in rats (7) (101). (Of interest, and perhaps signifi-
cance, is that the negative results regarding serum calcium response 
usually, if not always, were in experiments where the measurements 
were not made for seven or more days after the hypophysectomy.) Hypo-
physectomy in dogs, rabbits, monkeys, and rats has, however, been 
reported to result in atrophy and degeneration of the parathyroid 
tissue (13) (55) (57) (92) (102). In 1972, Salzer (80) reported a 
13.5 percent reduction in rat parathyroid cell nuclear size and altera-
tions in secretory granules following hypophysectomy . Negative 
results were reported, however, in the dog (11). Removal of the 
pituitary has also been observed to decrease the rat's ability to 
counter a challenge to its serum calcium concentrations (80) (81) (82). 
Since extirpation of the pituitary in toads can result in serum 
calcium and parathyroid tissue perturbation, replacement therapy pro-
vided another avenue of inquiry. Shapiro (85) (86) found that while 
hypophysectomy reduced the serum calcium to 7.4 mg/100 ml, injection 
of an anterior pituitary extract then increased the serum calcium to 
8.9 mg/100 ml. 
Anterior pituitary extracts have also been reported to increase 
serum calcium concentrations in intact animals. Work on dogs (8) (37) 
(43) (64), rats (8), guinea pigs (37) (38), and cats (85) demonstrated 
that an extract of the hypohysis can increase serum calcium concentra-
tions above normal. Hypertrophy of parathyroid glands in rats and 
7 
rabbits (8) and hypertrophy and hyperplasia of the glands in rabbits 
(53) has been reported following anterior pituitary extract injections. 
Parathyroidectomy followed by injections of the same extracts used in 
many of the positive experiments above resulted in no change in serum 
calcium concentration in dogs and rats (64) (79). 
Of the known pituitary hormones, three have been implicated in 
plasma calcium anomalies by indirect evidence. Growth Hormone (GH) 
has been considered a possible secretagogue of PTH (61). Hyperpara-
thyroidism has also been occasionally associated with acromegaly (97). 
Thyrotropin (TSH) has been implicated because of an occasional concom-
itant occurrence of pseudohypoparathyroidism and thyrotropin deficiency 
(105). Similarly, a prolactin deficiency has been reported in some 
patients with pseudohypoparathyroidism (29). A study on mud puppies 
has also implicated prolactin (72). 
In 1934, Hertz and Kranes (52) produced an extract which appeared 
to stimulate parathyroid activity sufficiently for them to theorize 
about the possibility of a separate "parathyreotropic" action origi-
nating in the anterior pituitary. Houssay (55) in 1936, reviewed the 
literature and formalized the concept of a "parathyrotropic hormone" 
in the anterior pituitary. The indirect evidence has also led to a 
negative interpretation (21). An "hypophyseal parathyrotropic hormone" 
was suggested by Salzer (80) in 1972 which would serve to meet endogen-
ous calcium requirements of organisms under special circumstances such 
as lactation. 
The major purpose of this dissertation was to investigate the 
I 
possibility of a direct pituitary-parathyroid relationship. The work 
was divided into four main segments: 1) measure the acute effect of 
8 
hypophysectomy on the serum calcium of rats, 2) measure the effect of 
injecting a pituitary extract on the serum calcium of cows, 3) establish 
a perfusion system which would allow a direct, minute to minute assess-
ment of effect of suspected secretagogues on parathyroid glands, and 
4) assess the direct response of perfused parathyroid gland to various 
pituitary extracts and hormones. 
CHAPTER III 
METHODOLOGY 
The investigation described in this dissertation used three 
experimental approaches: hypophysectomy, pituitary extract injec-
tions, and "in vitro" parathyroid gland perfusion. The two major 
responses observed were plasma calcium and immunoreactive parathyroid 
hormone (iPTH) concentration changes. 
Hypophysectomy 
In this operation, male Wistar strain rats weighing 220 grams 
(± 20 grams) were used. The pituitary was removed from eight animals 
(anesthesized with ether) by suction using an 18 gauge needle inserted 
through the auditory canal into the sella tursica (58) . A sham 
operation was performed on 12 similar rats for control purposes. 
Immediately after the operation, each animal was marked for identifi-
cation and injected with 1.0 cc "Liquamycin" intra-peritoneally. 
Two control animals were reanesthesized immediately after their 
sham operation and an 8 cc sample of blood removed from the abdominal 
aorta. Two drops of heparin (1000 U/ml) from a 20 gauge needle were 
added to the sample to retard coagulation. The samples were immediately 
centrifuged, the plasma removed and frozen at -70°c. Samples were taken 
from control (sham operated) and hypophysectomized animals at 24, 36, 
and 60 hours post operative and treated in a similar manner. Post 
9 
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mortem examination was performed on all animals to verify presence or 
total absence of the pituitary gland. Plasma was analyzed for calcium 
concentration. 
Pituitary Extract Injection 
In this procedure three calves were given a local anesthetic 
(2.5 mls of zylocaine) subcutaneously in the neck over the jugular 
vein. · A percutaneous catheter was inserted about eight inches into 
the jugular vein and sutured to the skin. This externalized catheter 
was kept patent by placing 0.5 ml of a weak heparin solution (2 U/ml) 
in the tube. The calves were allowed to adjust to their new situation 
for one hour. Blood samples (10 cc) were taken every·l5 minutes from 
the indwelling catheter for one hour following the adjustment period. 
An anterior pituitary extract (Preparation A) was injected via 
the catheter after these four control blood samples were drawn. The 
single injection of Preparation A was given as a saline solution at a 
dosage of 1.0 mg/67 kg body weight. This dosage was dissolved in 4 
cc of 0.9 percent saline and the catheter was then flushed with an 
additional 4 cc of saline. (See Appendix B·for a description of 
Preparation A.) 
A 10 cc blood sample was drawn every 15 minutes following the 
injection for 4. 5 to 9. 5 hours depending on the plasma calcium response .. 
All samples were then prepared with three drops of heparin (1000 U/ml) 
from a 20 gauge needle to prevent coagulation. The samples were centri-
fuged and the plasma immediately removed and frozen at -70°c. All food 
and water was withheld from the calves during the experiment. Samples 
were analyzed for plasma calcium concentration and iPTH. 
"In Vitro" Perfusion 
Bovine parathyroid glands were collected at a local abattoir. 
Inunediately upon decapitation (5 to 15 minutes after killing the 
animal) the superior.parathyroid glands were removed. A description 
of the gland location and identification in the slaughtered bovine 
11 
has been reported previously (54). The glands were removed with their 
arterial connection to the carotid artery attached and inunediately 
placed in cold (0-4°c) Hanks Balanced Salt Solution (HBSS) buffered 
to pH 7.4 for transportation to the laboratory. 
The parathyroid artery was cannulated with "intramedic" poly-
ethylene tubing P.E. 50 (I.D. 0.023", O.D. 0.038") and all accessory 
or branch arteries tied off. Any extraneous tissue was removed. The 
glands were then perfused with HBSS oxygenated with 95 percent o2 and 
5 percent co2 in a membrane oxygenator (Rocky Mountain Scientific 
Glassblowing Co., Denver, Colorado) and buffered with sodium bicar-
bonate to pH 7.4. Two perfusion rates, 0.5 and 1.0 ml/minute, were 
tested using a peristaltic, low-pulsatile pump (Sage model 375A). The 
perfusion pressure was monitored by a U-shaped mercury manometer. Two 
syringe pumps were connected into the perfusion system to enable the 
addition of test compounds. The glands were perfused in a reaction 
vessel surrounded by approximately 0.3 ml of HBSS. An overflow side-
arm allowed collection of the effluent (Figure 1). The entire system 
was maintained in an environment chamber at 37°c. Parathyroid effluent 
and perfusate samples were collected in one dram glass vials and inuned-
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In experiments which required a change in calcium concentration, 
either CaC12 or NazEDTA was added with a syringe pump (Harvard model 
975). Calcium concentration was decreased from the 4.5 mg/100 ml 
HBSS by adding NazEDTA in increasing steps every 10 minutes. An 
increase was affected by adding CaC12 in increasing amounts to the 
HBSS perfusate at 10 minute intervals. Samples were collected at the 
end of every 10 minute period. The glands were perfused, therefore, 
13 
at each calcium concentration for 10 minutes prior to sample collection. 
Seven pituitary preparations dissolved in 0.9 percent saline and 
a control solution of 0.9 percent saline were individually added to the 
HBSS to test for secretagogue activity. Table I shows the major known 
hormonal activity and the concentration at which each preparation was 
perfused through the parathyroid glands. (Appendix B through H des-
cribes each preparation in detail.) In addition, Preparation A was 
repeatedly frozen and thawed (12 cycles) and tested on the "in vitro" 
perfused parathyroid glands. Each preparation was tested for twenty 
minute.s. 
Radio immunoassay 
A radioimmunoassay (RIA) of parathyroid hormone was first des-
cribed in 1963 (17). The specific procedures used in the work in 
this dissertation have been fully detailed elsewhere (48) (84) (89). 
Of great importance for the current studies, was the antibody 
specificity used. Two antibody populations with different antigenic 
specificity were used: GP-5 and R-4. The PTH molecule is an 84 amino 
acid polypeptide, the first 34 of which comprise the biologically 
















TSH 0.007, 0.011, 0.015, 
14 
0.023, and 0.030 mg/ml 
TSH 0.017 IU/ml 
GR 0.004 IU/ml 
LH 12.2 ng/ml 
PROLACTIN 0.25 IU/ml 
ADH 0.0018 IU/ml 
OXYTOCIN 0.0025 IU/ml 
15 
animo acid sequence terminus of the PTH molecule in a rabbit. It is 
specific for this biologically active fragment and its antigen detec-
tion in this work will be referred to as "n-iPTH". The GP-5 antibody 
was cultivated against the entire 1-84 amino acid sequence in guinea 
pigs. Fortuitously, the GP-5 antibody population appears to be 
specific for the carboxy (animo acid sequence 35-84) terminus of the 
antigen PTH molecule. The antigen detected by the GP-5 antibody which 
reacts only to the non-biologically active portion will be referred to 
as "c-iPTH." 
Calcium Determinations 
Calcium concentrations were determined by a flourometric titra-
tion method (19). This technique utilizes a dye, calcein, which 
flouresces in the presence of calcium ions. The mixture is then 
titrated with EGTA until the flourescence disappears. Measurements 
were automated with a "Fiske Calcium Titrator, model 700." 
Enzyme Determinations 
Enzyme analysis was performed with "Dow Diagnostic Kits" for 
serum glutamic oxalacetic transaminase (GOT), lactate dehydrogenase 
(LDH), and acid phosphatase. The GOT (3) (4) and LDH (100) tests 
were based on ultraviolet spectral detection of NADH changes. The 
acid phosphatase determination was based on production of thyrnolphtha-
lein and subsequent combination with a blue chromogen (79). 
Histological Preparations 
Tissue for histological examination was fixed in 10 percent 
buffered formalin for 48 to 60 hours. Paraffin embedded sections 
were stained with hematoxylin-eosin. Examination was made of freshly 
removed parathyroid glands, glands perfused for eight hours at 1.0 
and 0.5 ml/minute, and non-perfused glands which were left in a 37°c 




"In Vitro" Perfusion Technique 
Figure 2 represents the c-iPTH secretory response over an eight 
hour perfusion period. These four glands were perfused with 4.5 mg 
calcium/100 ml HBSS at a rate of 1.0 ml/minute. The secretory rate 
fluctuated less than ± 10 percent from the average over the entire 
perfusion period. The perfusion pressure under these conditions 
also remained relatively constant until the 7 to 8 hour interval 
when it increased from an average of 45 to 85 nun Hg. 
Perfusion under the same conditions except at a slower rate (0.5 
ml/minute) resulted in a different response. Figure 3 depicts this 
pattern which was primarily a decreasing output of c-iPTH with time. 
The average secretory rate of these five glands increased, then was 
reduced a total of 75 percent in eight hours. Concurrently, the 
average perfusion pressure increased progressively for a total change 
of 20 mm Hg. Enzyme analysis of perfusate from these glands are shown 
in Figure 4. No LDH was detected. GOT and acid phosphatase concen-
trations did not change significantly during the eight hour perfusion 
period. 
The response of four glands exposed to anoxia for approximately 
one hour and perfused at 1.0 ml/minute is illustrated in Figure 5. 
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Figure 2, Parathyroid glands perfused "in vitro" with oxygenated HBSS. 
(Calcium concentration = 4.5 mg/100 ml, temperature = 37°c, 
pH buffered to 7.4 with sodium bicarbonate, and a perfusion 
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Figure 3. Parathyroid glands perfused "in vitro" with oxygenated HBSS at a rate of 
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Figure 5. Effect of Anoxia on parathyroid gland secretion when per-
fused at 1.0 ml/mi nute. Average initial secretory rate 
was 5 ng/100 mg tissue/minute. 
secretion even after the oxygen was restored. In the six hour period 
the hormone output was reduced by 60 percent. 
Changes in c-iPTH secretion in response to changes in perfusate 
calcium concentrations for nine glands are represented in Figure 6. 
22 
A decrease in calcium concentration stimulated c-iPTH secretion while 
an increase inhibited secretion. The basal secretory rate upon which 
the percent stimulation or inhibition was based was the secretory rate 
exhibited at the simulated normocalcemic concentration of 5.0 mg/100 
ml. An increase in total calcium above 6.5 mg/100 ml failed to elicit 
further suppression of c-iPTH secretion. These glands were perfused 
at 1.0 ml/minute. 
Table II compares the histological appearance of the parathyroid 
tissue under various conditions. Although the appearance of all the 
experimental tissue samples deviated from the freshly fixed tissue, 
only that perfused at 1.0 ml/minute had foci of acini and cords of 
normal appearing chief cells. This tissue did, however, reflect the 
greatest degree of separation of the connective tissue stroma. 
Samples (3.5 ml) of effluent were collected in empty glass vials, 
vials coated with bovine serum albumin (BSA), and vials containing 0.1 
ml of human plasma and frozen.immediately to -70°c. Assayed for c-iPTH 
48 to 60 hours later, the samples revealed no significant differences. 
Other samples collected in glass vials were repeatedly assayed for 
c-iPTH over a six-month period. No significant differences in the 
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Figure 6. Dose response of parathyroid gland secretory rate to calcium 





HISTOLOGY OF PARATHYROID GLANDS 
8 hour Perfused Perfused 
Control Incubation 1 ml/min. 0.5 ml/min. 
Nucleus: 
Distinct Basophilia x x 
Pale Basophilia x x x 
Distinct Nucleolus x x x x 
Pyknotic x x 
Chromatin Clumping 
on nuclear membrane x 
Cytoplasm: 
Distinct Eosinophilia x x 
Pale Eosinophilia x x x 
Vacuolation x x 
Connective Tissue Strama: 
Compact x x 




Intact x x x x 
Capillary Endothelium 
Intact x x 
Capillary Endothelum 
Disrupted x x 
Hypophysectomy 
As reviewed in Chapter II, ablation of the pituitary has been 
reported to yield contradictory results. Figure 7 represents the 
results of this current study on hypophysectomy of rats. The cal-
cium concentration decreased within 24 hours following extirpation 
and by 36 hours was 1.0 mg/100 ml plasma below the concentration of 
the control animals. The concentration appears to either stop 
decreasing or at least slow its rate of decrease by 36 hours and 
remains significantly below (10 mg/100 ml) the intact rats (11 mg/ 
100 ml). The difference in plasma calcium concentration is statis-
tically significant at P<0.01. 
Injection of Pituitary Preparation A 
25 
Injection of Preparation A (1.0 mg/67 kg body weight) into calves 
resulted in an increase in the plasma calcium concentration (Figure 8). 
The calcium increased an average of 1.1 mg/100 ml plasma. The time 
required to detect an increase varied from 0.75 to 2.5 hours post 
injection. Calcium concentration returned to the original value 3.5 
to 9 hours after the injection. The duration of the induced hyper-
calcemia ranged from 2.5 to 6.5 hours. 
The peripheral plasma c-iPTH concentration was also measured 
following the injection. No significant change was detected between 
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Response of "In Vitro" Perfused Parathyroid 
Gland to Suspected Secretagogues 
28 
Parathyroid gland secretory rate response to Preparation A was 
examined at simulated normocalcemia (4.5 mg/100 ml) and simulated 
hypercalcemia (6. 5 mg/100 ml). The glands were perfused at 1. 0 ml/ 
minute. Stimulation of seven glands for 20 minutes with 0.015 mg/ 
ml at 4.5 mg calcium/100 ml resulted in an average increase of 30 
percent in the c-iPTH secretion (Figure 9). The same samples mea-
sured for n-iPTH showed a 56 percent average stimulation (Figure 10). 
The c-iPTH required 50 minutes after cessation of stimulation to 
return to the prestimulation secretory rate. In contrast, the n-iPTH 
required only 20 minutes. Stimulation of six glands for 20 minutes 
with 0.015 mg/ml of Preparation A at 6.5 mg calcium/100 ml HBSS 
resulted in an average increase of 60 percent in c-iPTH secretion 
(Figure 11). The same samples measured for n-iPTH showed an 88 per-
cent average stimulation (Figure 12). As with the stimulation at 
normocalcemia, the hypercalcemic samples displayed a quicker return 
to prestimulatory rate of secretion (10 minutes) for n-iPTH than for 
the c-iPTH, which had not completely returned by 50 minutes. 
A partial dose response curve under normocalcemic conditions is 
depicted in Figure 13. The curve was constructed based on 19 responses 
distributed over the five dosages tested. 
The response of five glands to the carrier media (0.9 percent 
saline) were tested (Figure 14). No stimulation or inhibition of 
c-iPTH was found. Six glands tested for secretagogue activity of 
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Figure 9. Direct stimulation of c-iPTH secretion in " i n vitro" perf used parathyroid 
glands by pituit ary Preparation A. (Perf usion rate = 1 . 0 ml/minute, 
calcium conc£ntrat i on = 4.5 mg/100 ml.) Pre- stimulatory rate was 
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Figure 10. Direct stimulation of n-iPTH in "in vitro" perfused 
parathyroid glands by pituitary Preparation A. 
(Perfusion rate = 1 . 0 ml/minute, calcium concen-
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Figure 11. Direct stimulation 6f c-iPTH under hypercalcemic 
conditions (6.5 mg/100 ml) in "in vitro" per-
fused parathyroid glands by pituitary Preparation 
A. (Perfusion rate= 1.0 ml/minute~) Pre-
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Figure 12. Direct stimulation of n-iPTH under hypercalcemic 
condition in "in vitro" perfused parathyroid glands 
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Figure 13. Dose response curve for the effect of pituitary 
Preparation A on c-iPTH secretion in "in vitro" 
perfused parathyroid glands. (Perfusion rate = 
1.0 ml/minute, calcium concentration = 4.5 mg/ 
100 ml.) Average secretory rate at 0.007 mg/ml 
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Figure 14. C-iPTH secretion observed with exposure of "in vitro" parathyroid 
glands to 0.9 percent saline. (Perfusion rate = 1.0 ml/minute, 




gave essentially the same negative response (Figure 15). That is, there 
was no stimulation or inhibition of c-iPTH or n-iPTH activity observed. 
Each of the Preparations B through G were tested individually on 
five glands at the concentrations indicated in Table I. No apparent 
stimulation or inhibition of either c-iPTH or n-iPTH was observed for 
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Figure 17. "In Vitro" secretion of c-iPTH and n-iPTH in response to Preparation C. 
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Figure 18. "In Vitro" secretion of c-iPTH and n-iPTH in response to Preparation D. 
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Figure 19. "In Vitro" secretion of c-iPTH and n-iPTH in response to Preparation E. 
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"In Vitro" Perfusion of Parathyroid Glands 
At least four methods for the isolated or "in vitro" study of para-
thyroid function have been developed. An "in situ" perfusion technique 
was developed in 1942 (74) and later modified for improved control (31). 
Parathyroid gland tissue slice incubations were used in 1934 with 
limited success (94). Modifications of this approach have increased 
its utility (12) (40) (49). Disperse cell systems or cultures have 
also proved of limited effectiveness (33) (66) (99). Most recently 
a parathyroid explant superfusion culture system has provided some 
advantages over the previous methods (71). These techniques, either 
singularly or in combination, exhibited one or more of the following 
disadvantages: 1) parathyroid tissue was not completely isolated 
from other glandular tissue which may interfere with interpretations 
of results, 2) minute to minute changes in secretory activity could 
not be measured, 3) PTH was not always secreted, and/or 4) they 
required sterile conditions. 
The purpose of developing a new technique for examining parathyroid . 
hormone (PTH) secretory activity was to eliminate these disadvantages. 
Additionally, the desire was to reduce the need for experimental ani-
mals; to use a simple, but well defined perfusion media; to be able 
43 
, I 
to conduct experiments for six or more hours on a functionally stable 
and responsive gland; and to have a simple and economical technique. 
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Criteria used to evaluate the viability of this new "in vitro" per-
fusion system were in general agreement with those suggested by Bern-
stein (16): 1) Organ function as indicated by secretion of iPTH, 
2) Haemodynamic factors as indicated by perfusion pressure changes, 
3) Evidence of cell destruction as indicated by enzyme release, 4) 
Anatomic studies as indicated by histologic appearance, and 5) Metabolic 
considerations loosely indicated by changes in color of the pH indicator 
phenol red. 
Both "in vivo" (.68) and "in vitro" (41) work appears to demonstrate 
that if the concentration of calcium and other affectors of PTH secre-
tory rate are held constant, the secretory rate is constant.· The para-
thyroid glands perfused at 1. 0 ml/minute with oxygenated HBSS reflected 
this pattern. Those glands deprived of oxygen for one hour failed to 
maintain their initial secretory rates. The parathyroid gland has also 
been shown to respond "in vivo" to changes in calcium ion concentration 
in an inverse sigmoid manner (.67). Since Figure 6 demonstrated that 
glands perfused at 1.0 ml/minute responded to changes in the calcium 
concentration, the criteria concerning organ function appears to be 
satisfied for this perfusion rate. 
A progressive increase in resistance to perfusate flow is often a 
problem in experimental perfusion systems (32). The glands perfused 
at the 1.0 ml/minute rate maintained a relatively constant pressure 
until the seven to eight hour perfusion period. Glands perfused at 
0.5 ml/minute showed a steady increase in pressure and therefore are 
not as satisfactory (73). 
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An increase in' the release of cellular enzymes has commonly been 
u.sed as an indicator of the loss of tissue viability (2). The enzymes 
chosen for monitoring in this study did not show a progressive increase, 
a pattern of release indicative of tissue failure in the glands perfused 
at 0.5 ml/minute. Monitoring these enzymes, therefore, cannot be used 
as a measure of gland viability in this system. 
A perfusion rate of 0.5 ml/minute is approximately the "in vivo" rate 
for thyroid tissue on an equivalent per unit weight basis (56). This 
rate, however, was not sufficient to maintain parathyroid organ function 
in the "in vitro" perfusion system. Although the 1.0 ml/minute rate 
caused more connective tissue separation, it tended to maintain the 
chief cells in a more normal· appearing state. 
As indicated by color change of the phenol red, no pH alterations 
were noted in any gland effluents. This may be due to the high perfus-
ion rate and relatively small mass of tissue. However, it should not 
go without note that if sufficient Na2EDTA was added to drop the pH 
below 7.0, the secretory rate of iPTH was drastically reduced. This is 
contrary to the increase expected from the resulting calcium ion concen-
tration decrease. 
A secretory rate in one superior parathyroid gland of approximately 
1.5 ng/Kg body weight/minute has been reported for calves "in vivo" at 
a calcium concentration of 9.0 mg/ml of plasma (67). This can be com-
puted to equal 77 ng/100 mg gland weight/minute if the ratio of 1.93 
mg of parathyroid tissue/Kg body weight (95) is assumed. An "in vitro" 
culture method has yielded a rate of approximately 400 ng/mg dry weight 
of gland/24 hours under similar conditions (41). This rate can be cal-
culated to be 9.5 ng/100 mg/minute if the dry weight is assumed to 
represent 33 percent of the wet weight. The average c-iPTH secretory 
rate recorded with the "in vitro" perfusion (1.0 ml/minute) system 
reported here at comparable calcium and magnesium ion concentrations 
was 5 ng/100 mg/minute. The range was quite wide, from 2 to 20 ng/100 
mg/minute. 
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The problem of loss of PTH during storage by adsorption to glass 
has been well established. Loss has been reduced by use of bovine 
serum albumin (BSA) and almost eliminated by the a,ddition of human 
serum (49). No loss of iPTH activity was observed under the conditions 
of the present study and neither BSA nor human plasma had an effect. 
The iPTH activity is very stable for at least six months when frozen 
at -70°c. 
Pituitary Stimulation of Parathyroid Glands 
The decrease in plasma calcium concentration in hypophysectomized 
rats verifies the results of positive reports reviewed in Chapter II. 
The transient increase in serum calcium concentration in calves 
following a pulse injection of pituitary Preparation A also confirms 
some of the reports reviewed in the literature survey. Both of these 
results are consistent with the concept of a parathyroid stimulating 
hormone located in the pituitary. The experiments do not, however, 
demonstrate a direct effect of the pituitary on the parathyroid secre-
tory rate. In fact the lack of detection of an increase in c-iPTH in 
peripheral plasma of the calves prior to the calcium concentration 
increase raises some questions concerning this hypothesis. The peri-
pheral plasma iPTH concentration, however, has been shown to be a rela-
tively insensitive measure of changes in iPTH secretory rate (68). 
There was, therefore, a need to directly examine the changes in the 
iPTH secretory rate in response to suspected secretagogues. 
Preparation A directly stimulated the "in vitro" perfused para-
thyroid glands at simulated normocalcemia and hypercalcemia. Both 
c-iPTH and n-iPTH showed a significant increase in secretory rate 
corresponding to the period of stimulation. And in both instances 
the stimulation was greater during hypercalcemia. This implies that 
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the pituitary factor is capable of overwhelming maximal calcium sup-
pression of the secretory rate. Previous work has shown that dibutylryl 
cyclic AMP (which mimics the effect of cyclic AMP) can stimulate the 
parathyroid gland under hypercalcemic suppression (103). Cyclic AMP 
is extremely sensitive to inhibition by calcium ions (34). The 
physiological significance of this greater response may be in estab-
lishing an heirarchy of parathyroid secretion regulating mechanisms. 
That is, the generally accepted concept of calcium as the predominate 
control may now be questioned. In addition, a cellular mechanism 
through which this stimulant acts may be sought. 
The importance of a different degree of stimulation of c-iPTH and 
n-iPTH observed in this experiment is evident in light of other work 
(10) (47) (91). Although it is known that fragments of the intact PTH 
molecule (amino acid sequence 1-84) can be degraded peripherally (47), 
secretion of fragments may also occur ·(91). The data presented in 
this dissertation indicates that not only can the pituitary stimulate 
secretion of c-iPTH (active and non-active molecules), but that n-iPTH 
(biologically active molecules) secretion was stimulated to a much 
greater degree. This preferential secretion occurred at both normo-
and hypercalcemia. This is consistent with the concept that the 
parathyroid gland can change its effective secretory rate by either 
changing the total secretory rate or the proportion of biologically 
active molecules it secretes (46) (84). 
Failure of the repeatedly frozen and thawed sample of Preparation 
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A to elicit a secretory response indicates that the physiological 
activity of the secretagogue can be denatured or degraded and it implies 
that the stimulating effect is a specific property, not merely a general 
property of all proteins. Since the carrier media (0.9 percent saline) 
did not ptimulate the gland when given alone, it can be eliminated as the 
secretagogue. 
None of the known hormones tested at concentrations approximately 
equal to that found .in Preparation A elicited an increase in the iPTH 
secretory rate. Although not known to be present in Preparation A, 
Prolactin also gave negative results when tested at a concentration 
reported in lactating females (9). Adrenocorticotrophic hormone (ACTH), 
melanocyte stimulating hormone ( -MSH), and -lipotropin have been 
reported (44) to decrease plasma calcium. Additionally, they do not 
appear to work via the thyroid, parathyroid, or adrenals. Therefore, 
they can also be eliminated as probable stimulants to parathyroid secre-
tory activity. 
The occurrence of calcium and parathyroid anomalies coincident 
with other hormonal anomalies, as reviewed in Chapter II, may repre-
sent a multiple endocrine syndrome or a parathyroid response to extremely 
high levels of other pituitary hormone. Since the occurrence of para-
thyroid lesions and plasma calcium abnormalities do not consistently 
occur in conjunction with hyper- or hyposecretion of the pituitary 
hormones, as reviewed in the literature survey, it is doubtful that 
the known pituitary hormones are the cause. Although a massive dose 
of GH given to rats over a 4 to 6 week period did appear to increase 
plasma calcium and iPTH (61), this may be an indirect effect or the 
GH preparation may have been contaminated with sufficient amounts of 
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a separate parathyrotropic substance to produce the effect. The action 
of GH on plasma calcium has been attributed to an indirect effect (35). 
According to this theory, GH causes a decrease in plasma phosphate which 
indirectly results in an increase in the plasma calcium concentration. 
As noted in Chapter IV, attempts to directly stimulate parathyroid secre-
tion with large doses of TSH failed. Parathyroid involvement in multi-
ple endocrine disorders are common. In one study of 85 cases, 88 per-
cent involved the parathyroid and pituitary glands together (14). Of 
these same 85 cases, 22 involved only the parathyroid and pituitary 
with no other hormonal involvement known. 
CHAPTER VI 
SUMMARY AND CONCLUSIONS 
The "in vitro" parathyroid gland perfusion system described in 
this dissertation has the following characteristics: 
1. maintains a functionally stable gland for 6 to 8 hours; 
2. the glands become functionally stable within 1 to 1.5 hours 
after perfusion begins; 
3. the glands are functionally responsive to stimuli; 
4. a loss of functional stability after 6 hours or when induced, 
as with anoxia. can usually be detected by an increase in per-
fusion pressure; 
5. dynamic secretory responses may be monitored on a minute by 
minute basis; 
6. when stored at -70°C, iPTH samples remain stable for six months. 
The pituitary gland may have a direct stimulatory influence on the 
parathyroid secretory rate under both physiological and pathological con-
ditions. The following observations have been made about the pituitary-
parathyroid relationship: 
1. Hypophysectomy in rats may reduce serum calcium concentration, 
but there appears to be other mitigating variables. 
2. Injection of a pituitary preparation can increase the serum 
calcium concentration in calves. 
so 
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3. The parathyroid gland, "in vitro" can be stimulated directly by 
a pituitary extract. 
4. The parathyroid stimulating factor in the pituitary preparation 
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APPENDIX A 
"Some General Features of Endocrine Influence on Metabolism." W.B. 
Cannon. 1925. Trans. Cong. Am. Physicians and Surgeons. XIII:31-
53. 
"The first proposition is that in an open system, such as our 
bodies represent, complex and subject to numberless disturbances, the 
very existence of a poised or steady state is in itself evidence that 
agencies are at hand keeping the balance, or ready to act in such a 
way as to keep the balance. The agencies may act antagonistically, 
... atonic action is also possible ..•. " 
"A second proposition is that, if the state remains steady, there 
is an automatic arrangement whereby any tendency towards change is 
effectively met by increased action of the factor or factors which 
resist the change." 
"A third proposition is that any factor which operates to main-
tain a steady state by action in one direction does not act at the same 
point in the opposite direction." 
"A fourth proposition, related to the third, is that factors which 
may be antagonistic in one region, where they effect a balance, may be 
co-operative in another region. It is necessary, therefore, to define 
closely the field of action of opposing factors in discussing a physio-
logical equilibrium." 
"A fifth proposition is that the system of checks which determines 
a balanced sta'te may not be constituted of only two antagonistic factors; 
on either side there may be two or more, brought into action at the same 
time or successively." 
"A sixth proposition is that when a physiological factor is known 
which can shift a steady state in one direction, it is reasonable to 




PITUITARY PREPARATION A* 
Known Hormones Present S~ecific Activity 
TSH 1. 0-1. 2 
ACTH < 0.05 
GH <0.2 
LH <0.2 
Oxytocin < 0.1 
ADH < 0.1 
Method of purification described in U.S. Patent No. 2,871,159 







Distributed by ICN Pharmaceutical, Inc., (2621 Miles Road, Cleveland, 
Ohio) as "Thryotropic Hormone," Catalog No. 103057. 
*This information supplied by ICN Pharmaceuticals. 
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APPENDIX C 
PITUITARY PREPARATION B* 






<0.Dl NIH-LH-Sl U/mg 
<0.025 NIN-FSH-Sl U/mg 
Method of preparation as described by Reichert, L.E. 1975. "Purifica-
tion of Anterior Pituitary Hormones (Ovine, Bovine, Rat, Rabbit)," in 
Methods in Enzymology, 37:360. 
Supplied courtesy of NIAMDD, as Bovine, NIH-TSH-B8. 
*This information supplied by NIAMDD. 
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APPENDIX D 
PITUITARY PREPARATION C* 
Known Hormones Present Specific Activity 
GR 0.81 IU/mg 
TSH 0.05 USPU/mg 
LR 0.025 NIH-LH-Sl U/mg 
Prolactin 0.50 IU/mg 
Method of preparation as described in Reichert, L.E. 1970. 
J. Clin. Endo. and Metab. 31:331. 
Supplied courtesy of NIAMDD, as Bovine, NIH-GH-Bl8. 
*This information supplied by NIAMDD. 
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APPENDIX E 
PITUITARY PREPARATION D* 
Known Hormones Present Content 
LH 2.5 ug 
(normal plasma concentration 1-lOng/ml) 
Prepared by Dr. L.E. Reichert, Emory University, Atlanta, Georgia. 
Supplied courtesy of L.E. Reichert, Emory University, through Dr. R.J. 
Orts, Oklahoma State University as LH-LER (Batch No. 1056C-2). 
*This information supplied courtesy of Dr. L.E. Reichert. 
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APPENDIX F 
PITUITARY PREPARATION E* 
Known Hormones Present Specific Activity 
Pro lac tin 29.2 IU/mg 
Prepared by Sigma Chemical Co., St. Louis. 
Distributed by Sigma Chemical Co. (P.O. Box 14508, St. Louis, Missouri) 
as "Luteotropic Hormone" catalog no. L4876. 
*This information supplied by Sigma Chemical Company. 
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APPENDIX G 
PITUITARY PREPARATION F* 
Known Hormones Present Specific Activity 
ADH 370 IU/mg 
Prepared synthetically by Bach Chemical. 
Distributed by Bach Chemical (4077 Glencoe, Marina Del Rey, California) 
as "(Arg8)-Vasopressin", Catalog no. 8747. 
*This information supplied by Bach Chemical. 
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APPENDIX H 
PITUITARY PREPARATION G* 
Known Hormone Present Specific Activity 
Oxytocin 500 IU/mg 
Prepared synthetically by Bach Chemical. 
Distributed by Bach Chemical (4077 Glencoe, Marina Del Rey, California) 
as "Oxytocin", Catalog no. 5693. 
*This information supplied by Bach Chemical. 
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